Winningham Rick E

SEC CIK: 0001302443

SEC filings (opens in a new tab)

In the past year, 2 open-market sale filings worth $1.66M and no purchases.

Current role at each company

TBPH Theravance Biopharma, Inc.CHIEF EXECUTIVE OFFICERas of Sep 24, 2026
JAZZ Jazz Pharmaceuticals plcDirectoras of Sep 2, 2026

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $1.66M; 2 filings
Net: −$1.66M; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Winningham Rick E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

JAZZ Jazz Pharmaceuticals plc

Director5 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
May 27, 2026 (view filing)	May 22	5 days	Winningham Rick EDirector	SSale	−2.74K	$241.57	−$662.1K	−22.3%9.57K after
Nov 20, 2025 (view filing)	Nov 18	2 days	Winningham Rick EDirector	SSale	−5.50K	$180.86	−$994.7K	−38.2%8.89K after
Aug 15, 2023 (view filing)	Aug 14	1 day	Winningham Rick EDirector	SSale	−1.24K	$138.16	−$171.5K	−10.6%10.4K after
Aug 9, 2022 (view filing)	Aug 8	1 day	Winningham Rick EDirector	SSale	−1.09K	$152.32	−$165.9K	−11.2%8.61K after
Aug 10, 2021 (view filing)	Aug 6	4 days	Winningham Rick EDirector	SSale	−1.31K	$147.96	−$193.2K	−15.5%7.14K after

TBPH Theravance Biopharma, Inc.

CHIEF EXECUTIVE OFFICER1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Dec 16, 2022 (view filing)	Dec 14	2 days	Winningham Rick ECHIEF EXECUTIVE OFFICER	SSale	−50.0K	$11.19	−$559.5K	−3.6%1.35M after